Antidepressant-like effects of two commercially available products of Hypericum perforatum in the forced swim test: A long-term study

Journal of Medicinal Plants Research

Volumn 4, Issue 2, 2010, Pages 131-137

  Lozano Hernández, René ^a   Rodríguez Landa, Juan Francisco ^a   Hernández Figueroa, Jesús David ^a   Saavedra, Margarita ^a   Ramos Morales, Fernando Rafael ^a   Cruz Sánchez, Jesús Samuel ^a  

^a UNIVERSIDAD VERACRUZANA   (Mexico)

Author keywords

Antidepressant; Fluoxetine; Forced swim test; Hypericaceae; Hypericum perforatum; Open field test; Rats

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; HIPERIKAN; HYPERICIN; HYPERICUM PERFORATUM EXTRACT; REMOTIV; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FORCED SWIMMING TEST; HYPERICUM PERFORATUM; IMMOBILIZATION; LOCOMOTION; MALE; NONHUMAN; OPEN FIELD TEST; RAT;

CLUSIACEAE; HYPERICUM PERFORATUM; RATTUS; RATTUS NORVEGICUS;

EID: 76149145022     PISSN: 19960875     EISSN: 19960875     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Barnes J, Anderson LA, Phillipson D (2001). St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties. J. Pharm. Pharmacol. 53:583-600.
2. Bilia AR, Bergonzi MC, Morgenni F, Mazzi G, Vincieri FF (2001). Evaluation of chemical stability of St. John's wort commercial extract and some preparations. Int. J. Pharm. 213:199-208.
3. Butterweck V, Schmidt M (2007). St. John's wort: role of active compounds for its mechanism of action and efficacy. Wien. Med. Wochenschr., 157:356-361.
4. Butterweck V, Jürgenliemk G, Nahrstedt A, Winterhoff H (2000). Flavonoids from Hypericum perforatum show antidepressant activity in the forced swimming test. Planta Med., 66:3-6.
5. Butterweck V, Wall A, Liefländer-Wulf U, Winterhoff H, Nahrstedt A (1997). Effects of the total extract and fractions of Hypericum perforatum in animal assays for antidepressant activity. Pharmacopsychiatry, 30:117-124.
6. Calapai G, Crupi A, Firenzuoli F, Costantino G, Inferrera G, Campo GM, Caputi AP (1999). Effects of Hypericum perforatum on levels of 5-hydroxytryptamine, noradrenaline and dopamine in the cortex, diencephalon and brainstem of the rat. J. Pharm. Pharmacol., 51:723-728.
7. Cervo L, Rozio M, Ekalle-Soppo CB, Guiso G, Morazzoni P, Caccia S (2002). Role of hyperforin in the antidepressant-like activity of Hypericum perforatum extracts. Psycopharmacol., 164:423-428.
8. Contreras CM, Molina M, Saavedra M, Martínez-Mota L (2000). Lateral septal neuronal firing rate increases during proestrus-estrus in the rat. Physiol. Behav., 68:279-284.
9. Contreras CM, Rodríguez-Landa JF, Gutiérrez-García AG, Bernal-Morales B (2001). The lowest effective dose of fluoxetine in the forced swim test significantly affects the firing rate of lateral septal nucleus neurons in the rat. J. Psychopharmacol., 15:231-236.
10. Cott JM (1997). In vitro receptor binding and enzyme inhibition by Hypericum perforatum extract. Pharmacopsychiatry,30:108-112.
11. De Vry J, Maurel S, Schreiber R, de Beun R, Jentzsch KR (1999). Comparison of hypericum extracts with imipramine and fluoxetine in animal models of depression and alcoholism. Eur. Neuropsychopharmacol., 9:461-468.
12. Espejo EF, Miñano FJ (1999). Prefrontocortical dopamine depletion induces antidepressant-like effects in rats and alters the profile of desipramine during Porsolt's test. Neuroscience, 88:609-615.
13. Gambarana C, Giachetti D (2005). Efficacy in behavioural models of antidepressant activity. In Muller WE (ed). St. John's Wort and Its Active Principles in Depression and Anxiety, Basel: Birkhäuser Verlag, pp. 59-71.
14. Guilhermano LG, Ortiz L, Ferigolo M, Barros HM (2004). Commercially available Hypericum perforatum extracts do not decrease immobility of rats in the forced swimming test. Prog. Neuropsychopharmacol. Biol. Psychiatry, 28:49-55.
15. Gutiérrez-García AG, Contreras CM, Mendoza-López MR, Cruz-Sánchez S, García-Barradas O, Rodríguez-Landa JF, Bernal-Morales B (2006). A single session of emotional stress produces anxiety in Wistar rats. Behav. Brain Res., 167:30-35.
16. Hirano K, Kato Y, Uchida S, Sugimoto Y, Yamada J, Umegaki K, Yamada S (2004). Effects of oral administration of extracts of Hypericum perforatum (St John's wort) on brain serotonin transporter, serotonin uptake and behaviour in mice. J. Pharm. Pharmacol., 56:1589-1595.
17. Hostettmann K, Wolfender JL (2005). Phytochemistry. In Müller WE (ed). St. John's Wort and Its Active Principles in Depression and Anxiety, Basel: Birkhäuser Verlag, pp. 5-20.
18. Kasper S, Gastpar M, Müller WE, Volz HP, Dienel A, Kieser M, Möller HJ (2008). Efficacy of St. John's wort extracts WS® 5570 in acute treatment of mild depression: a reanalysis of data from controlled clinical trials. Eur. Arch. Psychiatr. Clin. Neurosci. 258:59-63.
19. López-Rubalcava C, Lucki I (2000). Strain differences in the behavioral effects of antidepressant drugs in the rat forced swimming test. Neuropsychopharmacol. 22:191-199.
20. Mennini T, Gobbi M (2004). The antidepressant mechanism of Hypericum perforatum. Life Sci. 75:1021-1027.
21. Müller WE, Singer A, Wonnemman M (2001). Hyperforin: antidepressant activity by a novel mechanism of action. Pharmacopsychiatry. 34:S98-S102.
22. National Research Council (1996). Guide for the Care and Use of Laboratory Animals: A Report of the Institute of Laboratory Animal Resource Committee on the Care and Use of Laboratory Animals [NIH publication no. 85-23]. U.S. Department of Health and Human Services: Washington DC.
23. Nöldner M, Schötz K (2002). Rutin is essential for the antidepressant activity of Hypericum perforatum extracts in the forced swimming test. Planta Med. 68:577-580.
24. Norma Oficial Mexicana NOM-062-ZOO-1999 (1999). Especificaciones Técnicas para la Producción, Cuidado y Uso de los Animales de Laboratorio. Secretaría de Agricultura, Ganadería, Desarrollo Rural, Pesca y Alimentación: México DF.
25. Page ME, Detke MJ, Dalvi A, Kirby LG, Lucki I (1999). Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test. Psychopharmacology (Berl). 147:162-167.
26. Panocka I, Perfumi M, Angeletti S, Ciccocioppo R, Massi M (2000). Effects of Hypericum perforatum on ethanol intake, and on behavioral despair: a search for the neurochemical systems involved. Pharmacol. Biochem. Behav. 66:105-111.
27. Porsolt RD, Le Pichon M, Jalfre M (1977). Depression: a new animal model sensitive to antidepressant treatments. Nature. 266:730-732.
28. Rahimi R, Nikfar S, Abdollahi M (2009). Efficacy and tolerability of Hypericum perforatum in major depressive disorder in comparison with selective serotonin reuptake inhibitors: a meta-analysis. Prog. Neuropsychopharmacol. Biol. Psychiatry. 33:118-127.
29. Rodríguez-Landa JF, Contreras CM, Gutiérrez-García AG, Bernal-Morales B (2003). Chronic, but not acute, clomipramine or fluoxetine treatment reduces the spontaneous firing rate in the mesoaccumbens neurons of the rat. Neuropsychobiol. 48:116-123.
30. Rodríguez-Landa JF, Contreras CM (2003). A review of clinical and experimental observations about antidepressant actions and side effects produced by Hypericum perforatum extracts. Phytomedicine, 10:688-699.
31. A receptor in the rat. J. Psychopharmacol., 21:76-84.
32. Rogóz Z, Skuza G, Leśkiewicz M, Budziszewska B (2008). Effects of co-administration of fluoxetine or tianeptine with metyrapone on immobility time and plasma corticosterone concentration in rats subjected to the forced swim test. Pharmacol. Rep., 60:880-888.
33. Tortoriello J, Zamilpa A, Herrera A, Romero-Cerecero O (2003). Determination of hypericin and hyperforin content in different phytopharmaceuticals and dietary supplements containing hypericum perforatum extract. Salud Mental, 26:56-63.
34. 1A agonists measured with the forced swim test. Psychopharmacol. 101:497-504.